Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Bladder diary, urinalysis and residual-volume assessment

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
A result that signals obstruction or serious disease

A diary or scan must not delay care for anuria, painful acute retention, sepsis, visible haematuria, clot retention, renal impairment, a solitary obstructed kidney or neurological features suggesting cauda equina syndrome.

Action: Assess observations, urine output, pain, abdomen and relevant neurology immediately; drain a painfully retained bladder within an appropriate acute pathway, send indicated blood and urine tests, and obtain urgent urological, medical or neurological review rather than repeating routine continence measurements.

Synopsis

Use three simple first-line assessments to phenotype lower-urinary-tract symptoms, detect infection or systemic disease, and recognise impaired emptying without overtesting uncomplicated incontinence.

  • Ask every woman presenting with urinary incontinence for a urine sample and dip for blood, glucose, protein, leucocytes and nitrites.
  • Interpret leucocytes and nitrites with symptoms: a dipstick is not a stand-alone diagnosis of UTI and asymptomatic bacteriuria is not treated routinely.
  • A bladder diary should cover at least three representative days and record timing and volume of drinks and voids, urgency, leakage, pads and relevant activities.
  • The diary distinguishes frequency from polyuria, reveals nocturnal patterns and links leakage to exertion or urgency; it does not prove a person's account true or false.
  • Measure post-void residual when symptoms suggest voiding dysfunction or recurrent UTI, not as a universal screening test in uncomplicated incontinence.
  • Prefer portable bladder ultrasound to catheterisation because it is more acceptable and causes fewer adverse events.
  • Record the voided volume, time since void and scan conditions; NICE does not define one universal residual-volume cutoff for women.
  • Do not use pad testing, cystoscopy or CT, MRI or X-ray routinely for urinary incontinence alone; each should answer a separate clinical question.

Key red flags

Inability to void with a painful or palpable bladder, oliguria, rising creatinine or systemic illness needs urgent assessment for retention and obstruction.

Visible haematuria, clot retention or persistent non-visible haematuria must follow the relevant haematuria and suspected-cancer pathway rather than being attributed to incontinence.

Fever, rigors, flank pain, hypotension or vomiting with urinary symptoms suggests upper-tract infection or sepsis and requires prompt treatment.

A high or persistent residual with saddle sensory change, leg weakness or new bowel dysfunction is a neurological emergency.

Glycosuria with polyuria, weight loss, thirst or acute illness requires diabetes assessment; proteinuria or renal impairment needs renal evaluation.

Investigation priorities

01
Minimum three-day bladder diaryFirst step

Quantify intake, output, timing, urgency and leakage during representative daily routines.

Management branches

Diary collectionCapture ordinary bladder behaviour

Urinary incontinence, urgency, frequency or nocturia is being assessed.

  1. Explain the purpose and provide a measured container or suitable method, asking for at least three days spanning ordinary variation.
  2. Record drinks, every voided volume, urgency, leakage, pad use, sleep and the activity surrounding episodes without deliberately changing habits.
  3. Review the diary with the person, separating storage symptoms, stress triggers, excessive intake, polyuria and night-time patterns before setting goals.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG123 urinary incontinence assessment
  • NICE QS77 bladder diaries and lifestyle changes
  • NHS urinary incontinence diagnosis
  • NHS urinary incontinence symptoms

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom